Our findings indicated that the expression of the HSD17B1 protein was moderate in normal BLCA, whereas it was medium to low in high-grade urothelial carcinoma patients' tissues (Fig. 2B). This evidence concerns the gene HSD17B1 and urothelial carcinoma.